Premium
Smart Watches for Heart Rate Assessment in Arrhythmias
Author(s) -
J Sajeev,
J Cooke
Publication year - 2018
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.4_13826
Subject(s) - medicine , cardiology , medical emergency
in a population-based cohort. Furthermore, we describe the role of PD-L2 and several additional TME markers which predict survival with conventional therapies in FL. To our knowledge this is the first description of PD-L2 as a prognosticator in any tumour subtype. Importantly, the methods used to define TME biomarkers were applicable with archival tissue, which is essential for translational application. These TME biomarkers are independent and additive to new state-ofthe-art prognostic models. Incorporation of immune-effectors and immune-checkpoints into a new clincoimmuno-genetic prognosticator has the potential to improve risk stratification of FL patients and should be further validated in additional cohorts.